BowRon SRL
The score of BowRon shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +181 % Total assets +23 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
BowRon's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jul 2026
- Year ended 31 Dec 2024filed on 15 Apr 2025
- Year ended 31 Dec 2023filed on 27 Jun 2024
BowRon's financial analysis
- Solvency84.6%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of BowRon
BowRon's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0795.728.216
- VAT number
- BE0795728216
- Peppol
- Registered · 0208:0795728216 · as of 07 Nov 2026
- Legal form
- SRL
- Incorporated
- 04 Jan 2023
- Registered office
- 8301 Knokke-Heist
- Latest accounts
- 2025 · filed on 29 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
BowRon (SRL) has been based in Knokke-Heist since 2023, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 8,040 € and equity of 7,182 €; its revenue is not published. Its solvency stands at 84.6%, above the median of its sector (44.2%).
Companies similar to BowRon
Companies in the same business, of comparable size and area, outside its group.
- Hubert Services Management Retail sale of pharmaceutical products Estinnes · balance sheet 65,144 €
- Wasopharma Retail sale of pharmaceutical products Nivelles · balance sheet 11,298 €
- PMI Construction Retail sale of pharmaceutical products Arlon · balance sheet 11,405 €
- InEssence Studio Retail sale of pharmaceutical products Auderghem · balance sheet 29,309 €
- Farma & Fit Retail sale of pharmaceutical products Rotselaar · balance sheet 71,427 €
- Faromco Retail sale of pharmaceutical products Hemiksem · balance sheet 36,931 €
- Quantum Satis Retail sale of pharmaceutical products Zele · balance sheet 34,289 €
- Pharmacycle Retail sale of pharmaceutical products Brussels · balance sheet 41,191 €
Frequently asked questions about BowRon
What is the revenue of BowRon?
BowRon files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of BowRon?
In Belgium, the VAT number is the company number prefixed with BE: BE0795728216 for BowRon, if the company is VAT-registered. Its company number (CBE) is 0795.728.216.
Where is the registered office of BowRon?
According to the CBE register, the registered office of BowRon is in 8301 Knokke-Heist.
What is the equity of BowRon?
At the close of the 2025 financial year, the equity of BowRon amounts to 7,182 €, a solvency of 84.6% of total assets.
Who manages BowRon?
The register lists 2 active mandates at BowRon. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of BowRon
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →